374 related articles for article (PubMed ID: 17453526)
1. Creatine depletion and altered fatty acid metabolism in diseased human hearts: clinical investigation using 1H magnetic resonance spectroscopy and 123I BMIPP myocardial scintigraphy.
Nakae I; Mitsunami K; Matsuo S; Horie M
Acta Radiol; 2007 May; 48(4):436-43. PubMed ID: 17453526
[TBL] [Abstract][Full Text] [Related]
2. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine.
Nakae I; Mitsunami K; Yoshino T; Omura T; Tsutamoto T; Matsumoto T; Morikawa S; Inubushi T; Horie M
J Card Fail; 2010 Oct; 16(10):812-22. PubMed ID: 20932463
[TBL] [Abstract][Full Text] [Related]
3. The significance of 123I-BMIPP delayed scintigraphic imaging in cardiac patients.
Akashi YJ; Kida K; Suzuki K; Inoue K; Kawasaki K; Yamauchi M; Musha H; Anker SD
Int J Cardiol; 2007 Apr; 117(2):145-51. PubMed ID: 16843549
[TBL] [Abstract][Full Text] [Related]
4. Comparison of myocardial fatty acid metabolism with left ventricular function and perfusion in cardiomyopathies: by 123I-BMIPP SPECT and 99mTc-tetrofosmin electrocardiographically gated SPECT.
Zhao C; Shuke N; Okizaki A; Yamamoto W; Sato J; Ishikawa Y; Ohta T; Hasebe N; Kikuchi K; Aburano T
Ann Nucl Med; 2003 Oct; 17(7):541-8. PubMed ID: 14651352
[TBL] [Abstract][Full Text] [Related]
5. [Prediction of left ventricular functional recovery in patients with acute myocardial infarction using single photon emission computed tomography with thallium-201 and iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid].
Hashimoto A; Nakata T; Nagao K; Kobayashi H; Hase M; Yoshioka N; Tsuchihashi K; Yonekura S; Tanaka S; Iimura O
J Cardiol; 1995 Aug; 26(2):59-68. PubMed ID: 7674145
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between ventricular arrhythmias and myocardial fatty acid metabolism in patients with coronary heart disease: evaluation using iodine-123 beta-methyl-p-iodophenyl-pentadecanoic acid].
Mori H; Sakamoto T; Ueda Y; Yano K
J Cardiol; 1999 Aug; 34(2):61-9. PubMed ID: 10466087
[TBL] [Abstract][Full Text] [Related]
7. [Fatty acid metabolic and perfusion abnormalities in hypertrophied myocardium assessed by dual tracer tomography using thallium-201 and iodine-123-beta-methylpentadecanoic acid].
Kobayashi H; Nakata T; Han S; Takahashi N; Hashimoto A; Tsuchihashi K; Nagao K; Tanaka S; Shimamoto K; Iimura O
J Cardiol; 1994; 24(1):35-43. PubMed ID: 8158529
[TBL] [Abstract][Full Text] [Related]
8. [Is myocardial fatty acid metabolism different between hypertrophic cardiomyopathy and hypertensive hypertrophy?].
Narita M; Kurihara T; Usami M; Honda M
Kaku Igaku; 1994 Dec; 31(12):1465-76. PubMed ID: 7861646
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of 123I-BMIPP myocardial scintigraphy in patients with hypertrophic cardiomyopathy].
Ohtsuki K; Sugihara H; Umamoto I; Harada Y; Shiga K; Nakamura T; Nakagawa T; Azuma A; Kohno Y; Katsume H
Kokyu To Junkan; 1992 Feb; 40(2):175-81. PubMed ID: 1565884
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-enhanced MRI with iodine-123 BMIPP for detection of myocardial damage in hypertrophic cardiomyopathy.
Amano Y; Kumita S; Takayama M; Kumazaki T
AJR Am J Roentgenol; 2005 Aug; 185(2):312-8. PubMed ID: 16037498
[TBL] [Abstract][Full Text] [Related]
11. Impairment of BMIPP accumulation at junction of ventricular septum and left and right ventricular free walls in hypertrophic cardiomyopathy.
Ohtsuki K; Sugihara H; Kuribayashi T; Nakagawa M
J Nucl Med; 1999 Dec; 40(12):2007-13. PubMed ID: 10616878
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of 123I-beta-methyl iodophenyl pentadecanoic acid (BMIPP) myocardial scintigraphy in patients of chronic right ventricular overload--fatty acid metabolism in right ventricular myocardium].
Mutoh H
Kaku Igaku; 1997 Oct; 34(10):917-24. PubMed ID: 9404099
[TBL] [Abstract][Full Text] [Related]
13. [The characteristic feature of myocardial imaging with 123I-labeled 15-(p-iodophenyl)-3R,S-methylpentadecanoic acid in hypertrophic cardiomyopathy with asymmetric septal hypertrophy].
Ohtsuki K; Sugihara H; Ito K; Matsumoto K; Taniguchi Y; Terada K; Nakagawa T; Shima T; Kuribayashi T; Ochiai M
Kaku Igaku; 1995 Apr; 32(4):377-85. PubMed ID: 7776544
[TBL] [Abstract][Full Text] [Related]
14. Assessment of myocardial fatty acid metabolic abnormalities in patients with idiopathic dilated cardiomyopathy using 123I BMIPP SPECT: correlation with clinicopathological findings and clinical course.
Yazaki Y; Isobe M; Takahashi W; Kitabayashi H; Nishiyama O; Sekiguchi M; Takemura T
Heart; 1999 Feb; 81(2):153-9. PubMed ID: 9922350
[TBL] [Abstract][Full Text] [Related]
15. [Assessment of myocardial fatty acid metabolism in patients with angina pectoris and diabetes mellitus using 123I-BMIPP myocardial scintigraphy].
Ito K; Sugihara H; Tanabe T; Yuba T; Doue T; Adachi Y; Katoh S; Azuma A; Nakagawa M
Kaku Igaku; 2001 Nov; 38(6):699-705. PubMed ID: 11806080
[TBL] [Abstract][Full Text] [Related]
16. [The characteristics of myocardial fatty acid metabolism in patients with left ventricular hypertrophy].
Isobe N; Toyama T; Hoshizaki H; Oshima S; Taniguchi K; Iizuka T; Kanazawa N; Wakamatsu S; Arisaka H; Suzuki T; Nagai R; Inoue T; Endo K
Kaku Igaku; 1999 Sep; 36(7):725-33. PubMed ID: 10547982
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of hypertrophic cardiomyopathy: assessment by 123I-BMIPP (beta-methyl-p-(123I)iodophenyl pentadecanoic acid) myocardial single photon emission computed tomography.
Nishimura T; Nagata S; Uehara T; Morozumi T; Ishida Y; Nakata T; Iimura O; Kurata C; Wakabayashi Y; Sugihara H; Otsuki K; Wada T; Koga Y
Ann Nucl Med; 1996 Feb; 10(1):71-8. PubMed ID: 8814730
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of hypertrophic cardiomyopathy by myocardial scintigraphy using 123I-labelled 15-(p-iodophenyl)-3-R, S-methylpentadecanoic acid (123I-BMIPP).
Ohtsuki K; Sugihara H; Umamoto I; Nakamura T; Nakagawa T; Nakagawa M
Nucl Med Commun; 1994 Jun; 15(6):441-7. PubMed ID: 8078640
[TBL] [Abstract][Full Text] [Related]
19. [Phase 2 study of beta-methyl-p-(123I)-iodophenyl-pentadecanoic acid, a myocardial imaging agent for evaluating myocardial fatty acid metabolism].
Torizuka K; Yonekura Y; Nishimura T; Tamaki N; Uehara T
Kaku Igaku; 1992 Mar; 29(3):305-17. PubMed ID: 1583804
[TBL] [Abstract][Full Text] [Related]
20. [Prediction of effect of beta-blocker therapy in patients with dilated cardiomyopathy by using 123I-BMIPP, 123I-MIBG scintigraphy].
Inoue A; Yamazaki J; Nanjou S; Togane Y; Amano H
Kaku Igaku; 2001 Mar; 38(2):99-104. PubMed ID: 11345771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
